MiMedx Group (MDXG) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
MiMedx Group (MDXG) PT Raised to $15 at Needham & Company as Momentum Continues
February 27, 2015 8:34 AM ESTNeedham & Company analyst Mike Matson reiterated a Strong Buy rating and boosted his price target on MiMedx Group (NASDAQ: MDXG) to $15.00 (from $13.00) following Q4 results.
Matson commented, "MDXG's 4Q14 revenue was consistent with its 1/12/15 preannouncement while EPS met consensus. Management maintained its previously... More
